trending Market Intelligence /marketintelligence/en/news-insights/trending/_wdjloxwpnvfbl_acum6iq2 content esgSubNav
In This List

Anatara Lifesciences CEO retires; interim named

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Anatara Lifesciences CEO retires; interim named

Anatara Lifesciences Ltd. said Mel Bridges retired as CEO.

Executive director Tracie Ramsdale was named interim CEO.

Jay Hetzel, a nonexecutive director of Anatara, was also appointed interim chairman.

Brisbane, Australia-based Anatara Lifesciences develops nonantibiotic oral solutions for gastrointestinal diseases.